Abstract
Vitamin D insufficiency has been linked to multiple conditions including bone disease, respiratory disease, cardiovascular disease, diabetes, and cancer. Observational studies indicate lower healthcare costs and healthcare utilization with sufficient vitamin D levels. The secondary aims of our previously published pragmatic clinical trial of vitamin D3 supplementation were comparisons of healthcare costs and healthcare utilization. Comparisons were made between the vitamin D3 at 5000 IU supplementation group and a non-supplemented control group. Costs of care between the groups were not statistically different. Vitamin D3 supplementation reduced healthcare utilization in four major categories: hospitalizations for any reason (rate difference: -0.19 per 1000 person-days, 95%-CI: -0.21 to -0.17 per 1000 person-days, p < 0.0001); ICU admissions for any reason (rate difference: -0.06 per 1000 person-days, 95%-CI: -0.08 to -0.04 per 1000 person-days, p < 0.0001); emergency room visits for any reason (rate difference: -0.26 per 1000 person-days, 95%-CI: -0.46 to -0.05 per 1000 person-days, p = 0.0131; and hospitalizations due to Covid-19 (rate difference: -8.47X10−3 per 1000 person-days, 95%-CI: -0.02 to -1.05X10−3 per 1000 person-days, p = 0.0253). Appropriately powered studies of longer duration are recommended for replication of these utilization findings and analysis of cost differences.
Competing Interest Statement
All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: T.L.B., P.J.L., T.C., B.B., K.Q.N., H.G., D.T. and M.A.M. have employment relationships with the Won Sook Chung Foundation. All authors had no financial relationships with any third party organizations that might have an interest in the submitted work in the previous three years. T.L.B. and K.H. are members of the Cooper University Hospital Institutional Review Board (CUH IRB) in the roles of unaffiliated scientist and affiliated biostatistician, respectively. Per the CUH IRB SOPs and HHS federal regulation 45 CFR 46.107(e), T.L.B. and K.H. left the meeting before any motions were made on this study; were not present for any final discussions regarding the study; and did not participate on any votes regarding this study. This is reflected in the CUH IRB meeting minutes. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Clinical Trial
NCT04596657
Funding Statement
This research was funded by the Won Sook Chung Foundation, grant number 310500749. Vitamin D capsules were donated to the study by Res-Q Vital D3, N3 Oceanic Inc, Pennsburg, PA, USA.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Cooper University Hospital Institutional Review Board of Cooper University Health Care gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
lariccip{at}pennmedicine.upenn.edu (P.J.L.); cafaro-teresa{at}cooperhealth.edu (T.C.); bebando{at}gmail.com (B.B.); brobyntl{at}rowan.edu (T.L.B.); ng-kevin{at}cooperhealth.edu; pharmhand95{at}gmail.com (H.G.); thewinger{at}aol.com (D.T.); mam43{at}aol.com (M.A.M.); dockyu{at}gmail.com (M.K.C.)
roy-satyajeet{at}cooperhealth.edu (S.R.); alantsai{at}gmail.com (A.T.)
john-epoh-di-bato{at}cooperhealth.edu (D.J.); hunter-krystal{at}cooperhealth.edu (K.H.)
vanhelmond-noud{at}cooperhealth.edu (N.v.H.)